Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 51 days ago
Share
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
612 patients around the world
Available in
Spain, United States, Argentina
Abivax S.A.
4
Research sites
612
Patients around the world
This study is for people with
Ulcerative colitis
Moderate/severe ulcerative colitis
Requirements for the patient
From 16 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Instituto de Investigaciones Clínicas Quilmes
Recruiting
View site
Sarmiento 315, Quilmes, Buenos Aires, Argentina
https://www.iicquilmes.com.ar
STAT Research - CABA
Recruiting
View site
Av. Callao 875, CABA, Buenos Aires
Hospital Italiano de Buenos Aires - CABA, Buenos Aires
Recruiting
View site
Juan Domingo Perón 4190, Piso 1, Ciudad Autónoma de Buenos Aires, C1181ACH
Hospital Privado de Córdoba
View site
Naciones Unidas 346, Córdoba
See details
Contact us
Contact us
Sponsor
Abivax S.A.
Conditions
Moderate/severe ulcerative colitis
Requirements
From 16 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT05507203
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent